About Us

Our technology platform is purpose-built for payers, providers, employers, and their advisory partners to manage the transition to and ongoing performance of value-based care. We are equipped to meet our clients where they are on their value-based care journey by delivering solutions that address their unique technology and risk tolerance needs. Ranging from SaaS, cloud-enabled to on-premise delivery, a unified data lake connects our analytics, population health, and payment technology solutions. For each stage of value-based care, from upside-only incentives to full-risk global capitation, our solutions are actuarially-driven through descriptive, predictive, and prescriptive analytics and are specifically designed to improve clinical, financial and operational outcomes.

Based in Greenwich, CT, Cedar Gate is private equity backed by GTCR, a leading Chicago-based private equity firm, Ascension Ventures, a strategic healthcare venture firm, and Cobalt Ventures, the investment subsidiary of BCBS of Kansas City.

Meet Our Executive Team

Dave-Snow-square
David B. Snow, Jr.

Chairman & CEO

Mr. Snow is a nationally recognized healthcare executive with 40 years of experience leading Fortune 50 companies, health plans, hospitals and several innovative healthcare start-ups. He has been featured in numerous articles and is a frequently sought after public speaker. Mr. Snow was acknowledged as one of America’s Best CEO’s by Institutional Investor in 2008, and in 2010, he was named #27 on the Harvard Business Review list of “Best Performing CEO’s in the World”. Additionally, Mr. Snow was recognized as the regional E&Y Entrepreneur of the Year in 2006 along with being a national finalist, and was also named a regional finalist as the Cedar Gate CEO in 2021.

Mr. Snow is currently the Founder, Chairman and CEO of Cedar Gate Technologies, a provider of technology-powered end-to-end solutions designed to enable customer success in value-based care, encompassing enterprise data management, analytics, population health, bundles and capitation technologies, along with other managed and consulting services.

Prior to Cedar Gate Technologies, Mr. Snow was the Chairman & CEO of Medco Health Solutions, a Fortune 34 company. Mr. Snow took Medco public in 2003 and grew it from $30 billion to $72 billion in revenue over a 9 year period. Before Medco, Mr. Snow held positions including President and COO of Empire Blue Cross Blue Shield, EVP of Oxford Health Plans and President of HMO New Jersey for US Healthcare. Earlier in his career, Mr. Snow founded his first company, Managed Healthcare Systems (later renamed AmeriChoice), which was later sold to United Healthcare.

He is Chairman of the Board for Teladoc, Inc., which is publicly traded on the NYSE. Mr. Snow is also on the Board of Premise Health and he is Chairman of the Board of Visitors for the Fuqua School of Business at Duke University.

Mr. Snow holds a Bachelors Degree from Bates College, and a Masters Degree in Healthcare Administration from the Fuqua School of Business, Duke University. He and his family reside in Darien, Connecticut.

Morris
David L. Morris

Chief Commercial Officer

David Morris has over 30 years of operational and executive leadership experience at blue chip companies throughout the healthcare ecosystem.

David drives client success across the value-based healthcare landscape by addressing the technology and service needs of the Payer, Provider, Employer, Pharma and Retail markets. He serves as Chief Commercial Officer with oversight of all commercial efforts, including Market Strategy, Sales and Client Success Management.

Prior to joining Cedar Gate Technologies, David held key leadership roles as EVP and Chief Commercial Officer with Citra Health Solutions, Chief Revenue Officer with Eliza Corporation (acquired by HMS Holdings), Senior Vice President of Global Sales and Services with Bupa Health Dialog (acquired by Rite Aid), National Vice President of Healthcare for SAP America, IMS Health (acquired by IQVIA), Baxter and George Washington University (GWU) Medical Center.

David received his undergraduate degree from George Washington University’s School of Government and Business Administration and now resides in Boston, MA.

Rubino
Richard Rubino

Chief Financial Officer

Richard Rubino was named the Executive Vice President and Chief Financial Officer of Cedar Gate Technologies in August 2021, building upon over 40 years of experience as a finance and business leader. Prior to joining Cedar Gate, he served as Chief Financial Officer of Aerie Pharmaceuticals from October 2012 through July 2021. Prior to Aerie, he served as Senior Vice President, Finance and Chief Financial Officer of Medco Health Solutions, Inc. from March 2008 through April 2012, when the company merged with Express Scripts, Inc. Richard has consistently had oversight responsibility for all financial activities, including accounting, reporting, accounts receivable, treasury, tax, planning, analysis, procurement, audit, investor relations and financial evaluation.  Prior to his role as Chief Financial Officer at Medco, he served as Medco’s Controller and also the Vice President of Planning, where he was responsible for financial, business and strategic planning.

 

Richard also held various positions at International Business Machines Corporation and Price Waterhouse & Co. He is an inactive Certified Public Accountant and received his BS in Accounting from Manhattan College.  Richard has been a Director of the Northside Center for Child Development since 2009 and has served as the Treasurer and is currently President of the Board where he is engaged in fundraising matters and strategic initiatives.

Galvin
Michael Galvin

Chief Operating Officer

Michael Galvin is a 30-plus year banking and healthcare information technology and operations veteran. As COO for Cedar Gate Technologies, Michael is committed to fostering a culture of transparency and accountability and creating business value in the form of customer satisfaction, financial performance and systems reliability.

His 23 years with Empire BlueCross BlueShield as a technology leader, combined with his decade of service at Medco and Express Scripts as a innovator and transformation leader, gives Michael a unique perspective on the challenges facing the healthcare industry and have armed him with the tools needed to achieve his vision for Cedar Gate Technologies as a leader on the technology and data information capabilities while also achieving operating excellence.

Michael received his bachelor’s in business administration from Manhattan College.

Dye
James Dye

President, Bundled Payment Division

James Dye has more than 30 years’ experience in accelerating performance for healthcare organizations. As President of the Bundled Payment Division, Jamie is responsible for all aspects of Cedar Gate’s bundled payment business strategy, growth and operations.

Prior to Cedar Gate, Jamie served as the Chief Development Officer Global Healthcare Alliance (GHA), the bundled payment solutions provider acquired by Cedar Gate Technologies in late 2018. Prior to GHA, Mr. Dye was Chief Development Officer of MedSynergies (now Optum360 Ambulatory Services), a for-profit ambulatory services company focused on improving physician enterprise performance. Under Jamie’s leadership MedSynergies grew its business from a local to national ambulatory services provider, resulting in the company’s strategic acquisition by Optum in 2014.

Jamie’s prior experience also includes a 20-year tenure with Perot Systems helping to build the organization into a multi-billion-dollar market leader in healthcare services. He received his bachelor’s degree from the University of South Florida and his master’s degree in health law from Nova Southeastern University.

Rowe
David Rowe

Chief Marketing Officer

David Rowe leads strategic marketing, brand strategy, and integrated marketing communications at Cedar Gate. He has 22 years of experience in healthcare IT, focused on improving healthcare outcomes by connecting plan sponsors to care teams and their patients through advanced technologies.

Prior to joining Cedar Gate, David served as the Chief Marketing Officer of Enli Health Intelligence, the population health company acquired by Cedar Gate in December of 2021. Before Enli, he held executive marketing positions with WebMD, GE Healthcare, and Caradigm – the GE/Microsoft joint venture focused on big data and analytics.

David was an Ames Technology Scholar at Portland State University’s Graduate School of Business, where he earned a specialized MBA in the Management of Innovation & Technology. He earned his Bachelor of Arts in Anthropology from the University of California at San Diego.

Dominianni
Paul Dominianni

General Counsel

Paul Dominianni serves as the Chief Legal Officer for Cedar Gate, and also leads the company’s compliance efforts.

Paul has extensive experience in representing both providers and payors on a wide range of contractual, regulatory and risk management matters in all segments of the health care market. Paul’s experience includes senior legal positions with two Blue Cross/Blue Shield plans and several national managed care organizations. He brings an informed and customer focused orientation to his work.

Paul holds a BA from Syracuse University and a JD from the Boston University School of Law.

Meet Our Leadership Team

Bill McElmurryChief Payer Sales Officer
Chris SawickiChief Provider Sales Officer
Christopher StatenSVP, Finance
Dan SantmyerChief Actuary Officer
Darren BeckChief Strategic Sales Officer
Gabe CappucciChief Accounting Officer
Gina D. FordSVP, Marketing & Communications
Jeff RickChief Technology Officer
Julia PerrySVP, Enterprise Client Success
Julie DittaSVP, Enterprise Client Delivery
Ken BrownSVP, Client Solutions
Kevin StokesChief Infrastructure Officer
Michael PardesChief Information Officer
Oscar JonesChief Information Security Officer
Rajiv MahaleSVP, Analytic Products
Sherdell JonesVP, Human Resources
Steven ZanderChief Analytics Officer
Tim HukeChief Employer/ASO Sales Officer
Tobin LassenChief Bundle Solutions Officer
Valerie HaertelSVP, Investor Relations
Yvonne MannSVP, Value Based Care Operations

Meet Our Board Members

Dave-Snow-square
David B. Snow, Jr.Chairman & CEO

Cedar Gate Technologies

Dave-Snow-square
David B. Snow, Jr.

Chairman & CEO

Cedar Gate Technologies

Mr. Snow is a nationally recognized healthcare executive with 40 years of experience leading Fortune 50 companies, health plans, hospitals and several innovative healthcare start-ups. He has been featured in numerous articles and is a frequently sought after public speaker. Mr. Snow was acknowledged as one of America’s Best CEO’s by Institutional Investor in 2008, and in 2010, he was named #27 on the Harvard Business Review list of “Best Performing CEO’s in the World”. Additionally, Mr. Snow was recognized as the regional E&Y Entrepreneur of the Year in 2006 along with being a national finalist, and was also named a regional finalist as the Cedar Gate CEO in 2021.

Mr. Snow is currently the Founder, Chairman and CEO of Cedar Gate Technologies, a provider of technology-powered end-to-end solutions designed to enable customer success in value-based care, encompassing enterprise data management, analytics, population health, bundles and capitation technologies, along with other managed and consulting services.

Prior to Cedar Gate Technologies, Mr. Snow was the Chairman & CEO of Medco Health Solutions, a Fortune 34 company. Mr. Snow took Medco public in 2003 and grew it from $30 billion to $72 billion in revenue over a 9 year period. Before Medco, Mr. Snow held positions including President and COO of Empire Blue Cross Blue Shield, EVP of Oxford Health Plans and President of HMO New Jersey for US Healthcare. Earlier in his career, Mr. Snow founded his first company, Managed Healthcare Systems (later renamed AmeriChoice), which was later sold to United Healthcare.

He is Chairman of the Board for Teladoc, Inc., which is publicly traded on the NYSE. Mr. Snow is also on the Board of Premise Health and he is Chairman of the Board of Visitors for the Fuqua School of Business at Duke University.

Mr. Snow holds a Bachelors Degree from Bates College, and a Masters Degree in Healthcare Administration from the Fuqua School of Business, Duke University. He and his family reside in Darien, Connecticut.

Libby Alexander
Libby AlexanderFormer Chief Executive Officer, Former Vice Chairman

Connolly, Inc., Cotiviti

Libby Alexander
Libby Alexander

Former Chief Executive Officer, Former Vice Chairman

Connolly, Inc., Cotiviti

Libby Connolly Alexander is an experienced business leader and philanthropist who serves on the boards of several well-known businesses and organizations.  She served as Chief Executive Officer of Connolly, Inc. from 2012 to 2014, leading the company through its acquisition of iHealth Technologies. She then served as the Vice Chairman of the Board of Directors of the combined organization, Cotiviti, as it went public in May of 2016 at a market valuation of $2.55 billion.  Two years later, Cotiviti was acquired by Veritas Capital-backed healthcare data solutions provider Verscend at a transaction value of $4.89 billion.

Libby established her company’s healthcare practice in 1998 and was responsible for building it into a leader in the payment analytics and integrity space prior to the sale of the company.  Cotiviti’s clients included 20 of the top 25 largest U.S. healthcare insurers, eight of the top 10 U.S. retailers, and the Centers of Medicare and Medicaid (CMS).

Libby is also the author Figuring It Out, a memoir of her experience taking Connolly from a PC-driven data mining and analytics company into the untapped healthcare payment integrity industry, harnessing a growth engine along the way unlike any previously leveraged.

Libby serves on the boards of Cedar Gate Technologies, Tulane University, and the Eaglebrook School, and is a strategic advisor to Save the Sound as well as several other local community organizations.  She holds a BA from Tulane University.

Sean L. Cunningham
Sean L. CunninghamManaging Director

GTCR

Sean L. Cunningham
Sean L. Cunningham

Managing Director

GTCR

Sean joined GTCR in 2001 and is currently a Managing Director of the firm. He was previously a Consultant with The Boston Consulting Group. Sean holds an MBA from the Wharton School at the University of Pennsylvania as well as AB and BE degrees in engineering sciences from Dartmouth College.

Sean currently is a Director of Albany Molecular Research, Ceba-Tech, Cedar Gate Technologies, Cole-Parmer, Corza Health, Maravai LifeSciences, Regatta, Riverchase Dermatology, Sotera and Transaction Data Systems. He was instrumental in GTCR’s past investments in Cord Blood Registry, Devicor Medical Products, Graceway Pharmaceuticals and Ovation Pharmaceuticals.

Victor Kats
Victor KatsInvestments

Ascension Ventures

Victor Kats
Victor Kats

Investments

Ascension Ventures

Victor Kats has served as a member of our board of directors since December 2018. Mr. Kats currently serves as a Managing Partner of Seminal Capital Holdings, LLC and Co-Head of SemCap Health, its healthcare investment fund. He was previously a Managing Director at Ascension Ventures and led the investment in Cedar Gate Technologies. Prior to that, Mr. Kats was in healthcare technology and services operations as VP of Corporate Development at Allscripts Healthcare Solutions and VP of Business Development at Misys Healthcare Systems during the early adoption years of electronic health record systems.

Mr. Kats serves as member of the board of directors of Cedar Gate Technologies and Owl Insights, Inc. on behalf of Ascension Ventures, LLC, and served as director of VisitPay Inc., Vivify Health, Inc., Phreesia, Inc., and Voalte, Inc., among other investments. He is also on the UNC Health Foundation Board of Directors.

Mr. Kats received his BSBA degree from the University of North Carolina at Chapel Hill and his M.B.A. in Finance from the Wharton School of Business at the University of Pennsylvania in Philadelphia, Pennsylvania.

John2
John D. KosManaging Director

GTCR

John2
John D. Kos

Managing Director

GTCR

John joined GTCR in 2006 and is a Managing Director in the Healthcare group. Prior to joining GTCR, he worked as an Analyst in the Healthcare investment banking group of Citigroup Global Markets in New York. John holds an MBA with distinction from Harvard Business School and a BS in finance with highest honors from the University of Illinois.

He currently serves as a Director of Cedar Gate Technologies and Transaction Data Systems and works closely with Antylia Scientific, Experity and Water’s Edge/Riverchase Dermatology. He was previously involved in past GTCR investments CCS, Cole-Parmer, GreatCall and XIFIN.

Dr. David Levy
David Levy, MDChief Executive Officer

EHE Health

Dr. David Levy
David Levy, MD

Chief Executive Officer

EHE Health

Dr. David Levy is the Chief Executive Officer at EHE Health. He is an accomplished physician executive with a record of achievement in founding, leading, and/or turning around a variety of health care services companies focused on improving human health.

As a primary care physician and epidemiologist, Dr. Levy started his career in private practice in suburban New York City. There he founded Franklin Health Inc., (now owned by Optum), the innovator and leader in advocating for patients with highly complex illnesses. He then went on to PwC, and as a partner ultimately led its global health care business for several years. Dr. Levy serves on the boards of leading device, technology, and services companies in the US, Israel, and Brazil.

Dr. Levy is a renowned strategic thinker who has executed effective strategies for his own enterprises and a diverse set of public and private sector entities. Drawing on a vast network of business relationships, Dr. Levy brings global best-in-practice solutions to the healthcare industry.

Constantine Mihas
Constantine S. MihasCo-CEO & Managing Director

GTCR

Constantine Mihas
Constantine S. Mihas

Co-CEO & Managing Director

GTCR

Dean joined GTCR in 2001 and is currently a Co-CEO and Managing Director of the firm. Prior to joining GTCR, Dean was CEO and co-founder of Delray Farms, LLC, a specialty food retailer. Prior to that, Dean was with McKinsey & Company. Dean holds an MBA with distinction from the Harvard Business School and a BS with high distinction in finance and economics from the University of Illinois, Chicago.

Dean is head of the Healthcare group at GTCR and has been instrumental in building the firm’s expertise in pharma, life sciences and medical devices. He is currently a Director of Antylia Scientific, Ceba-Tech, Cedar Gate Technologies, Corza Health, Curia, Maravai LifeSciences, Resonetics, Sotera Health and TerSera Therapeutics. Dean was previously a Director of past GTCR investments, including Actient Pharmaceuticals, ATI Physical Therapy, Convergex, Cord Blood Registry, Crealta Pharmaceuticals, Curo Health Services, Dash, Devicor Medical Products, GreatCall, Managed Healthcare Associates, Ovation Pharmaceuticals, Riverchase Dermatology, TDS (formerly Rx30) and XIFIN.

Dean was highly involved with Chicago Public Media for over 10 years, serving as a board member and Chair of the Finance Committee.

Leslie Norwalk
Leslie NorwalkStrategic Counsel, Former Acting Administrator

Epstein Becker Green, P.C., CMS

Leslie Norwalk
Leslie Norwalk

Strategic Counsel, Former Acting Administrator

Epstein Becker Green, P.C., CMS

Leslie Norwalk is Strategic Counsel to Epstein Becker Green, P.C., EBG Advisors and National Health Advisors. She serves as an advisor to several private equity firms; and in addition to Cedar Gate, currently sits on the boards of directors of Arvinas, Magellan Health, Neurocrine Biosciences, NuVasive, Providence Service Corp., CareCentrix, Abode Healthcare, Linkwell Health. She is also a member of APCO Worldwide’s International Advisory Council.

Ms. Norwalk served the Bush Administration as the Acting Administrator for the Centers for Medicare & Medicaid Services (CMS). She managed the day-to-day operations of Medicare, Medicaid, State Child Health Insurance Programs, Survey and Certification of health care facilities and other federal health care initiatives. For four years prior to that, she was the agency’s Deputy Administrator, responsible for the implementation of the hundreds of changes made under the Medicare Modernization Act, including the Medicare Prescription Drug Benefit.
CMS has the second-largest budget outlay of the Federal Government, directly responsible for $1 out of every $3 spent on healthcare in the United States. The organization insures approximately a third of the population of the United States (more than 100 million beneficiaries) including the elderly, disabled, and some of the lowest income individuals in the country. CMS processes over one billion claims each year and contracts with approximately one million providers.

Prior to serving the Bush Administration, she practiced law in the Washington, D.C. office of Epstein Becker & Green, P.C. where she advised clients on a variety of health policy matters. She also served in the first Bush administration in the White House Office of Presidential Personnel, and the Office of the U.S. Trade Representative.

Ms. Norwalk, a native of Dayton, OH, earned a juris doctor degree from the George Mason University School of Law, where she was a Dean’s Scholar and an editor of the George Mason Law Review. She earned a bachelor’s degree, cum laude, in economics and international relations from Wellesley College.

Dr. Lee Sacks
Lee Sacks, MDFormer Chief Medical Officer (Retired)

Advocate Aurora Health

Dr. Lee Sacks
Lee Sacks, MD

Former Chief Medical Officer (Retired)

Advocate Aurora Health

Lee Sacks, M.D. retired as Chief Medical Officer of Advocate Aurora Health in August 2018.   In that role, he was responsible for safety, quality, population health, insurance, claims, risk management, research, and medical education.  He previously served as Executive Vice President, Chief Medical Officer of Advocate Health Care since 1997.    From 1995 – 2018, he served as the founding CEO of Advocate Health Partners (now d/b/a Advocate Physician Partners), a clinically integrated network that includes over 5,000 physicians.  He is a nationally recognized thought leader on value-based payment arrangements.  He currently serves as a physician executive in residence for the Health Management Academy, on the board of Cedar Gate Technologies, the Board of Trustees of Rosalind Franklin University of Medicine and Science, and on the advisory boards of Prealize and Project Connect.   He is an external reviewer for New England Journal of Medicine Catalyst.

Dr. Sacks is a fellow of the Institute of Medicine, Chicago.  He practiced family medicine for thirteen years in suburban Chicago.  Dr. Sacks earned a Bachelor of Science in chemical engineering at the University of Pennsylvania.  He received his medical degree from the University of Illinois College of Medicine and completed a family practice residency at Lutheran General Hospital in Park Ridge, IL.

Your browser is out-of-date!

Update your browser to view this website correctly. Outdated Browser

×